Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Daiichi Sankyo
Harvard Business School
Fuji
Citi
Teva
Merck
Queensland Health
QuintilesIMS
Argus Health

Generated: February 25, 2018

DrugPatentWatch Database Preview

NAPHAZOLINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Naphazoline Hydrochloride, and when can generic versions of Naphazoline Hydrochloride launch?

Naphazoline Hydrochloride is a drug marketed by Akorn Inc and Altaire Pharms Inc and is included in three NDAs.

The generic ingredient in NAPHAZOLINE HYDROCHLORIDE is naphazoline hydrochloride; pheniramine maleate. There are six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.

US Patents and Regulatory Information for NAPHAZOLINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc NAPHAZOLINE HYDROCHLORIDE naphazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 083590-001 Approved Prior to Jan 1, 1982 RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Akorn Inc NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 202795-001 Jan 24, 2013 OTC No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Altaire Pharms Inc NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE naphazoline hydrochloride; pheniramine maleate SOLUTION/DROPS;OPHTHALMIC 078208-001 Sep 27, 2010 OTC No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Mallinckrodt
Julphar
AstraZeneca
Express Scripts
Cerilliant
Moodys
US Department of Justice
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot